IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Historical Holders from Q3 2020 to Q3 2025

Type / Class
Debt / NOTE 1.500% 6/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
170,823,077
Holdings value
$177,255,350
% of all portfolios
0%
Number of holders
10
Number of buys
2
Number of sells
-3
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1

Period Principal Value Change Price Investors
2025 Q3 170,823,077 $177,255,350 -$449,580 $0.895 10
2025 Q2 167,434,077 $168,923,031 -$617,713 $0.8482 11
2025 Q1 165,440,927 $177,805,855 -$118,626 $0.8889 13
2024 Q4 162,485,927 $181,412,896 -$5,361,158 $0.9188 15
2024 Q3 174,660,250 $155,061,380 -$26,714,854 $0.8854 19
2024 Q2 199,579,000 $188,232,680 -$1,536,486 $0.9395 19
2024 Q1 197,210,000 $200,950,767 -$4,539,819 $1.01 26
2023 Q4 197,783,681 $214,752,759 -$57,796,947 $1.08 23
2023 Q3 253,984,309 $234,677,877 +$47,095,659 $0.9769 21
2023 Q2 195,096,314 $199,278,621 -$3,822,597 $1.02 17
2023 Q1 199,068,000 $199,949,244 +$3,671,564 $1 23
2022 Q4 193,506,792 $212,083,816 +$3,261,653 $1.09 26
2022 Q3 172,661,287 $175,938,133 -$19,057,125 $1.02 24
2022 Q2 191,310,000 $206,431,392 -$3,075,326 $1.08 21
2022 Q1 193,608,500 $227,878,494 -$1,405,092 $1.18 19
2021 Q4 195,546,000 $222,198,820 -$9,175,256 $1.14 19
2021 Q3 198,153,834 $243,379,250 +$25,811,035 $1.21 19
2021 Q2 176,649,934 $211,202,719 +$8,625,093 $1.2 18
2021 Q1 169,573,934 $191,711,949 -$4,712,158 $1.13 17
2020 Q4 173,803,000 $196,230,527 +$1,158,829 $1.13 17
2020 Q3 173,624,321 $169,841,000 +$169,841,000 $0.9763 18